other_material
confidence high
sentiment neutral
materiality 0.65
Indivior proposes re-domestication from UK to Delaware; shareholder vote set for Dec 11, 2025
Indivior Pharmaceuticals, Inc.
- Scheme circular filed: EGM on Dec 11, 2025 to vote on re-domestication via scheme of arrangement.
- New holding company would be Indivior Pharmaceuticals, Inc. (Delaware); shares to trade on Nasdaq.
- Court approval and shareholder vote required; SEC registration exemption under Section 3(a)(10).
- Indivior shares expected to cease trading on Nasdaq before effective date; new shares commence same day.
- Board unanimously recommends voting in favor.